NCT02844699
A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jul 31, 2016
Completion: Jan 31, 2018